All
Drug-resistant disease re-emerge, gain strength
February 1st 2014Key concerns regarding infectious diseases with cutaneous manifestations include the expanding reach of infections formerly thought rare and exotic, experts say. Meanwhile, they add, some infections rarely seen stateside in recent years are resurging.
PODCAST: A plethora of aesthetic products
February 1st 2014Cosmetic concerns are important to many of our patients. Among the difficulties faced by consumers is the blitz of advertising of new and presumably revolutionary products that can rejuvenate and preserve the youthful appearance of the skin. Many products make what sound like medical claims about the efficacy of these agents. Norman Levine, M.D., asked Zoe Draelos, M.D., the foremost authority on this subject, to discuss these issues with us.
The successful aesthetic consult
January 30th 2014Kent Remington, M.D., guides patients through his method for conducting a successful aesthetic consult, he told attendees at the MauiDerm 2014 meeting. Knowing a patient’s “real” reasons for aesthetic improvement - and shifting from a monotherapy toward performing a full-face rejuvenation following a multitherapeutic approach - are essential in achieving excellent aesthetic outcomes, he told attendees at the MauiDerm 2014 meeting.
More highlights from MauiDerm 2014
January 29th 2014New drugs, data and guidelines on acne and rosacea treatment were among the takeaways from days two and three of MauiDerm 2014. Presenters also described evidence-based suggestions for managing pigmentary disorders and updated information on infectious diseases.
Digital skin lesion analysis may help dermatologists classify skin lesions
January 29th 2014A multispectral digital skin lesion analysis device may be useful in helping clinicians to classify clinically ambiguous lesions, detect early melanomas in young adults, and identify outlier lesions that should be biopsied, according to a collection of posters presented at MauiDerm 2014.
Questionnaires measure quality-of-life impact of carcinomas
January 21st 2014In an effort to learn more about patients’ experiences with advanced basal cell carcinoma and basal cell carcinoma nevus syndrome, researchers have developed two new questionnaires to evaluate and assess the effects of the diseases.
FDA approves combo treatment for melanoma
January 14th 2014The Food and Drug Administration has approved GlaxoSmithKline’s Mekinist (trametinib) for use in combination with Tafinlar (dabrafenib) as a possible treatment for patients suffering from inoperable melanoma and certain types of metastatic melanoma.
Next generation technologies promise to enhance treatment of disease
January 1st 2014The implementation of next generation technologies coupled with the acquisition of a more in-depth knowledge of dermatologic diseases and conditions are proving to be very helpful in better treating and managing patients.